|
AMGN's Revenue Growth by Quarter and Year
Amgen Inc 's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| AMGN Revenue (in millions $) |
FY 2024 |
FY 2023 |
FY 2022 |
FY 2021 |
| IV Quarter |
December |
-
|
8,196.00
|
6,839.00
|
6,846.00
|
| III Quarter |
September |
-
|
6,903.00
|
6,652.00
|
6,706.00
|
| II Quarter |
June |
8,388.00
|
6,986.00
|
6,594.00
|
6,526.00
|
| I Quarter |
March |
7,447.00
|
6,105.00
|
6,238.00
|
5,901.00
|
| FY |
|
15,835.00
|
28,190.00
|
26,323.00
|
25,979.00
|
| AMGN Revenue second quarter 2024 Y/Y Growth Comment |
Amgen Inc achieved in the second quarter 2024, above Company average Revenue growth of 20.07% year on year, to $ 8,388.00 millions.
Looking into second quarter 2024 results within Biotechnology & Pharmaceuticals industry 9 other companies have achieved higher Revenue growth. While Amgen Inc ' s Revenue rise of 20.07% ranks overall at the positon no. 896 in the second quarter 2024.
|
| AMGN Revenue ( Y/Y Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
December |
- |
19.84 % |
-0.1 % |
3.2 % |
| III Quarter |
September |
- |
3.77 % |
-0.81 % |
4.41 % |
| II Quarter |
June |
20.07 % |
5.94 % |
1.04 % |
5.16 % |
| I Quarter |
March |
21.98 % |
-2.13 % |
5.71 % |
-4.22 % |
| FY |
|
- |
7.09 % |
1.32 % |
2.18 % |
AMGN Revenue (Quarter on Quarter Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
December |
- |
18.73 % |
2.81 % |
2.09 % |
| III Quarter |
September |
- |
-1.19 % |
0.88 % |
2.76 % |
| II Quarter |
June |
12.64 % |
14.43 % |
5.71 % |
10.59 % |
| I Quarter |
March |
-9.14 % |
-10.73 % |
-8.88 % |
-11.05 % |
| FY (Year on Year) |
|
- |
7.09 % |
1.32 % |
2.18 % |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 87.32 % |
6.38 % |
-2.75 % |
| (Dec 31 2013) |
|
(Sep. 30, 2009) |
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 87.32 % |
6.38 % |
-2.75 % |
| (Dec 31 2013) |
|
(Sep. 30, 2009) |
|
| Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024 |
Amgen Inc 's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 18.73 % |
1.77 % |
-11.81 % |
| (Dec 31 2023) |
|
|
| AMGN's II. Quarter Q/Q Revenue Comment |
Amgen Inc achieved in the II. Quarter 2024 above company average sequential Revenue rise of 12.64%, to $ 8,388.00 millions, from $7,447.00 millions in the first quarter.
Within Biotechnology & Pharmaceuticals industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Amgen Inc 's Revenue growth quarter on quarter, overall rank is 329. |
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 18.73 % |
1.77 % |
-11.81 % |
| (Dec 31 2023) |
|
|
| AMGN's II. Quarter Q/Q Revenue Comment |
Amgen Inc achieved in the II. Quarter 2024 above company average sequential Revenue rise of 12.64%, to $ 8,388.00 millions, from $7,447.00 millions in the first quarter.
Within Biotechnology & Pharmaceuticals industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Amgen Inc 's Revenue growth quarter on quarter, overall rank is 329. |
|
Amgen Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Jun 30 2024) |
12 Months Ending
(Mar 31 2024) |
12 Months Ending
(Dec 31 2023) |
12 Months Ending
(Sep 30 2023) |
12 Months Ending
(Jun 30 2023) |
| Cumulative Revenue 12 Months Ending |
$ 30,934.00 |
$ 29,532.00 |
$ 28,190.00 |
$ 26,833.00 |
$ 26,582.00 |
| Y / Y Revenue Growth (TTM) |
16.37 % |
12.76 % |
7.09 % |
1.91 % |
0.75 % |
| Year on Year Revenue Growth Overall
Ranking |
# 928 |
# 667 |
# 453 |
# 716 |
# 1115 |
| Seqeuential Revenue Change (TTM) |
4.75 % |
4.76 % |
5.06 % |
0.94 % |
1.5 % |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 1286 |
# 667 |
# 1520 |
# 790 |
# 1208 |
| Cumulative Revenue growth
Comment |
Amgen Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 16.37% year on year, to $ 30,934 millions if the fiscal year would have ended in Jun 30 2024.
Amgen Inc 's trailing twelve months Revenue growth was higher than company's average 6.38% and higher than 12.76% growth in Mar 31 2024.
But sequential increase was less at 4.75 % from $29532 millions recorded in twelve months ending a quarter before Caroline Simon went on.
There is slowdown in progress, more noticeable if you pay attention to the average Q/Q TTM historic advancement that is higher at 6.38% Caroline Simon noted.
The growth is even higher sequentially exhibited at 4.75 % increase from $29532 millions in twelve months ending a quarter before.
In the Healthcare sector 129 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 667 to 928. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
87.32 % |
6.38 % |
-2.75 % |
|
|
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
87.32 % |
6.38 % |
-2.75 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 19 |
| Sector |
# 209 |
| S&P 500 |
# 1286 |
|
| Cumulative Revenue growth
Comment |
Amgen Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 16.37% year on year, to $ 30,934 millions if the fiscal year would have ended in Jun 30 2024.
Amgen Inc 's trailing twelve months Revenue growth was higher than company's average 6.38% and higher than 12.76% growth in Mar 31 2024.
But from the previous reporting period rise was less at 4.75 % from $29532 millions recorded in twelve months ending a quarter before.
It appears to be drop-off in progress, more noticeable as we look at average Q/Q TTM historic advancement what is higher at 6.38%.
The momentum was even stronger sequentially exhibited at 4.75 % jump from $29532 millions in twelve months ending a quarter Mar 31 2024.
In the Healthcare sector 129 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 667 to 928. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
87.32 % |
6.38 % |
-2.75 % |
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
87.32 % |
6.38 % |
-2.75 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 19 |
| Sector |
# 209 |
| S&P 500 |
# 1286 |
|
34.48%